OTC Valuations Limited (OTC Val) has strengthened its team with the appointment of Dr. Paul Bergbusch to lead the organization’s technology function. He joins OTC Val as Chief Technology Officer, and will lead the effort to introduce the next generation of solutions further expanding the coverage for structured products and exotic derivatives under the OTC Val portfolio. He will be based in Vancouver.
As an expert in financial derivatives and systems engineering, Bergbusch brings a wealth of data analysis, derivatives modeling and systems development experience for pricing and processing all derivatives products. He holds a Ph.D. in Experimental Particle Physics from the University of British Columbia.
Bergbusch comes to the OTC Val team from BlueCrest Capital Management, one of the largest hedge funds in Europe. As head quantitative analyst for the equity derivatives desk, he was responsible for the modeling of volatility products, the development and analysis of trading strategies, and front office system integration. Paul has also held roles in systems architecture and software engineering at Macdonald Dettwiler, an aerospace engineering firm, and quantitative research and software development for exotic interest rate and fixed income products at FINCAD.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.
Early-stage merger and acquisition deals in Asia-Pacific show nearly 10% year-on-year growth in recent months.